Marcel Jenny
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marcel Jenny has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Dietmar Fuchs
Institute of Biological Chemistry, Medizinische Universität Innsbruck, Innsbruck, Austria
4 shared publications - Harald Schennach
Central Institute for Blood Transfusion, University Clinic Innsbruck, Innsbruck, Austria
3 shared publications - Martina Überall
Department of Secondary Vocational and General Education, University College of Teacher Education Tyrol, Innsbruck, Austria
2 shared publications - Sebastian Schroecksnadel
Division of Biological Chemistry, Biocenter, Medical University of Innsbruck, Innsbruck, Austria
2 shared publications Budi J Hidayat
1 shared publicationCathrine Zaknun
1 shared publication
Latest Publications
- 1 December 2012
- Published by American Scientific Publishers in Journal of Bionanoscience
- Vol. 6 (2) , 134-141
Peripheral Blood Mononuclear Cells versus Myelomonocytic Cell Line THP-1 to Test for Immumodulatory Properties of Chemicals
In the last decade there has been a strong increase in the use of engineered nanoparticles, but despite their growing presence and their exposure to humans only little is known about the potential risks for human health. Immune system regulatory circuits play a crucial role in the pathogenesis of a variety of human diseases including autoimmune syndromes and cancer. Interferences of nanoparticles with the immune system may begin at lower dose than toxicity of vital organ function becomes detectable. Moreover, when nanoparticles interfere with immunosurveillance, this will enhance their disease-propagating activities, e.g., when genotoxic effects may promote tumorigenesis. This review article discusses two cell-based methods which could be easily applied for the detection of immunomodulatory properties of nanoparticles. Th1-type cytokine interferon-γ (IFN-γ) is a central regulator within the pro-inflammatory immune response. Among other biochemical events, IFN-γ induces the enzymes GTP-cyclohydrolase I, which gives rise to neopterin production by activated human macrophages, and indoleamine 2,3-dioxygenase (IDO), which converts tryptophan to kynurenine. Accordingly, enhanced tryptophan degradation and neopterin formation are detected in the blood during several disease states involving a Th1-type immune activation such as virus infections, cancer and cardiovascular diseases and are of strong predictive value. To study the immunomodulatory potential of chemicals, unstimulated and stimulated peripheral blood mononuclear cells (PBMC) and myelomonocytic THP-1-Blue cells are applied in vitro. Neopterin formation (by ELISA) and tryptophan degradation (by HPLC) are monitored in the supernatants. In addition, expression of the central signal-transduction element nuclear factor kappa B (NF-κB) was recorded in THP-1-Blue cells, which are transfected with a corresponding NF-κB gene reporter system. Stimulation of PBMC with mitogen phytohaemagglutinin-L (PHA) strongly induces neopterin formation and tryptophan degradation in vitro. Similar effects are observed in THP-1-Blue cells stimulated with lipopolysaccharide and the close correlation with activation of NF-κB becomes evident. Cannabis compound cannabidiol was used to demonstrate the dose-dependent suppression of all the biochemical read-outs in both in vitro cell-based assays. Analysis of neopterin production and tryptophan degradation in freshly isolated human PBMCs is a useful way to measure the influence of compounds or chemicals on the interaction between T-cells and macrophages. The myelomonocytic cell line THP-1-Blue can be used as a convenient alternative, and both assays can be easily applied for the testing of chemicals but the effects of compounds on the T-cell/macrophage interaction will be missed when THP-1-Blue cells are used.
- 1 December 2012
- Published by American Scientific Publishers in Journal of Bionanoscience
- Vol. 6 (2) , 134-141
Peripheral Blood Mononuclear Cells versus Myelomonocytic Cell Line THP-1 to Test for Immumodulatory Properties of Chemicals
In the last decade there has been a strong increase in the use of engineered nanoparticles, but despite their growing presence and their exposure to humans only little is known about the potential risks for human health. Immune system regulatory circuits play a crucial role in the pathogenesis of a variety of human diseases including autoimmune syndromes and cancer. Interferences of nanoparticles with the immune system may begin at lower dose than toxicity of vital organ function becomes detectable. Moreover, when nanoparticles interfere with immunosurveillance, this will enhance their disease-propagating activities, e.g., when genotoxic effects may promote tumorigenesis. This review article discusses two cell-based methods which could be easily applied for the detection of immunomodulatory properties of nanoparticles. Th1-type cytokine interferon-γ (IFN-γ) is a central regulator within the pro-inflammatory immune response. Among other biochemical events, IFN-γ induces the enzymes GTP-cyclohydrolase I, which gives rise to neopterin production by activated human macrophages, and indoleamine 2,3-dioxygenase (IDO), which converts tryptophan to kynurenine. Accordingly, enhanced tryptophan degradation and neopterin formation are detected in the blood during several disease states involving a Th1-type immune activation such as virus infections, cancer and cardiovascular diseases and are of strong predictive value. To study the immunomodulatory potential of chemicals, unstimulated and stimulated peripheral blood mononuclear cells (PBMC) and myelomonocytic THP-1-Blue cells are applied in vitro. Neopterin formation (by ELISA) and tryptophan degradation (by HPLC) are monitored in the supernatants. In addition, expression of the central signal-transduction element nuclear factor kappa B (NF-κB) was recorded in THP-1-Blue cells, which are transfected with a corresponding NF-κB gene reporter system. Stimulation of PBMC with mitogen phytohaemagglutinin-L (PHA) strongly induces neopterin formation and tryptophan degradation in vitro. Similar effects are observed in THP-1-Blue cells stimulated with lipopolysaccharide and the close correlation with activation of NF-κB becomes evident. Cannabis compound cannabidiol was used to demonstrate the dose-dependent suppression of all the biochemical read-outs in both in vitro cell-based assays. Analysis of neopterin production and tryptophan degradation in freshly isolated human PBMCs is a useful way to measure the influence of compounds or chemicals on the interaction between T-cells and macrophages. The myelomonocytic cell line THP-1-Blue can be used as a convenient alternative, and both assays can be easily applied for the testing of chemicals but the effects of compounds on the T-cell/macrophage interaction will be missed when THP-1-Blue cells are used.
- 1 December 2012
- Published by American Scientific Publishers in Journal of Bionanoscience
- Vol. 6 (2) , 127-133
Comparison of InVitro Tests for Antioxidant Capacities and Immunomodulatory Properties of Chemicals
The increasing utilization of nanoparticles bears potential risks for human health as well as the environment. Many nanoparticles have been shown to influence cellular redox-circuits and immune system homeostasis. Some of them are potent oxidants that lead to oxidative stress, while some of them are potent antioxidants with the capability to scavenge reactive oxygen species. Therefore, the evaluation of the capacity of nanoparticles to interfere with redox-homeostasis and the immune system represents an important strategy to sensitively detect and predict potentially harmful effects of nanoparticles. Our study investigated and compared the antioxidant and immunomodulatory capacity of the well described antioxidants ebselen, sulforaphane (SFN) and vitamin E analogue Trolox employing three different methods, namely the oxygen radical absorbance capacity (ORAC) test, the cell-based antioxidant activity (CAA) assay and a cell culture model using peripheral blood mononuclear cells (PBMC) stimulated or not with 10 μg/ml mitogen phytohemagglutinin (PHA). In the PBMC assay, immunomodulatory effects mediated by compounds were determined by measurement of neopterin production and tryptophan degradation. Trolox showed high antioxidant capacity in the ORAC- and CAA-assay, while ebselen and SFN had almost no such effect. In contrast, Trolox had only little influence on PBMC, whereas ebselen and SFN suppressed neopterin production and tryptophan degradation in a dose dependent manner. This study shows that the three test systems used give different results regarding antioxidant capacities of compounds and their effect on the immune system. The more simple physicochemical tests, ORAC and CAA, cannot fully predict the capacity of compounds to interact with the immune system. This fact needs to be considered when the effects of nanoparticles on biological systems are being tested in vitro.
- 1 December 2012
- Published by American Scientific Publishers in Journal of Bionanoscience
- Vol. 6 (2) , 127-133
Comparison of InVitro Tests for Antioxidant Capacities and Immunomodulatory Properties of Chemicals
The increasing utilization of nanoparticles bears potential risks for human health as well as the environment. Many nanoparticles have been shown to influence cellular redox-circuits and immune system homeostasis. Some of them are potent oxidants that lead to oxidative stress, while some of them are potent antioxidants with the capability to scavenge reactive oxygen species. Therefore, the evaluation of the capacity of nanoparticles to interfere with redox-homeostasis and the immune system represents an important strategy to sensitively detect and predict potentially harmful effects of nanoparticles. Our study investigated and compared the antioxidant and immunomodulatory capacity of the well described antioxidants ebselen, sulforaphane (SFN) and vitamin E analogue Trolox employing three different methods, namely the oxygen radical absorbance capacity (ORAC) test, the cell-based antioxidant activity (CAA) assay and a cell culture model using peripheral blood mononuclear cells (PBMC) stimulated or not with 10 μg/ml mitogen phytohemagglutinin (PHA). In the PBMC assay, immunomodulatory effects mediated by compounds were determined by measurement of neopterin production and tryptophan degradation. Trolox showed high antioxidant capacity in the ORAC- and CAA-assay, while ebselen and SFN had almost no such effect. In contrast, Trolox had only little influence on PBMC, whereas ebselen and SFN suppressed neopterin production and tryptophan degradation in a dose dependent manner. This study shows that the three test systems used give different results regarding antioxidant capacities of compounds and their effect on the immune system. The more simple physicochemical tests, ORAC and CAA, cannot fully predict the capacity of compounds to interact with the immune system. This fact needs to be considered when the effects of nanoparticles on biological systems are being tested in vitro.
- 1 April 2010
- Vol. 33 (2) , 129-35
Bovine colostrum modulates immune activation cascades in human peripheral blood mononuclear cells in vitro.
Bovine colostrum (BC) is the thick yellow fluid a lactating cow gives to a suckling calf during its first days of life to support the growth of the calf and prevent gastrointestinal infections until the calf has synthesized its own active immune defense system. BC contains a complex system of immune factors and has a long history of use in traditional medicine. In an approach to evaluate the effects of bovine colostrum (BC) on the T-cell/macrophage interplay, we investigated and compared the capacity of BC containing low and high amounts of lactose and lactoferrin to modulate tryptophan degradation and neopterin formation in unstimulated and mitogen-stimulated human peripheral blood mononuclear cells (PBMC). The present study shows significant immunomodulatory effects of these BC preparations in human PBMC, either by enhancing or suppressing the occurrence of a Th-1 type immune response. The amount of lactose present in BC seems to diminish the activity of BC in our test system, since BC with higher amounts of lactose attenuated the stimulatory as well as the suppressive activity of BC.
- 1 April 2010
- Vol. 33 (2) , 129-35
Bovine colostrum modulates immune activation cascades in human peripheral blood mononuclear cells in vitro.
Bovine colostrum (BC) is the thick yellow fluid a lactating cow gives to a suckling calf during its first days of life to support the growth of the calf and prevent gastrointestinal infections until the calf has synthesized its own active immune defense system. BC contains a complex system of immune factors and has a long history of use in traditional medicine. In an approach to evaluate the effects of bovine colostrum (BC) on the T-cell/macrophage interplay, we investigated and compared the capacity of BC containing low and high amounts of lactose and lactoferrin to modulate tryptophan degradation and neopterin formation in unstimulated and mitogen-stimulated human peripheral blood mononuclear cells (PBMC). The present study shows significant immunomodulatory effects of these BC preparations in human PBMC, either by enhancing or suppressing the occurrence of a Th-1 type immune response. The amount of lactose present in BC seems to diminish the activity of BC in our test system, since BC with higher amounts of lactose attenuated the stimulatory as well as the suppressive activity of BC.
- Open Access
- 1 January 2005
- Published by Sakun Publishing House in Journal of Carcinogenesis
- Vol. 4 (1) , 15
Apoptosis induced by the Tibetan herbal remedy PADMA 28 in the T cell-derived lymphocytic leukaemia cell line CEM-C7H2
J Carcinog, Official publication of Carcenogenesis Press
- 1 January 2005
- Published by Sakun Publishing House in Journal of Carcinogenesis
- Vol. 4 (1) , 15
Open AccessApoptosis induced by the Tibetan herbal remedy PADMA 28 in the T cell-derived lymphocytic leukaemia cell line CEM-C7H2
J Carcinog, Official publication of Carcenogenesis Press
- 1 December 2003
- Vol. 5 (6) , 631-41
Defining the human targets of phorbol ester and diacylglycerol.
Phorbol esters (PEs) and their derivatives are potent tumor-promoting agents. The best known receptors for these substances are the novel and classical isotypes of protein kinase C (PKC), which bind PE and the physiological second messenger diacylglycerol (DAG) by cysteine-rich domains, the C1 domains. However, PKC is not the sole receptor of PE, a concept that has been largely ignored in the past. PE (in addition to DAG) also targets C1-containing receptors unrelated to PKC. In order to get a better insight into DAG/PE-mediated signaling and the pathways involved, it is necessary to first determine all ligand-interacting proteins. Employing various sources of data, 66 different C1-containing human proteins are presented and predictions of their DAG/PE-binding potential are attempted. Defining the entire set of key mediators for the physiological DAG responses and for PE-induced tumorigenesis may aid our understanding of signal integration and can also help to design new strategies for therapeutic cancer intervention.
- 1 December 2003
- Vol. 5 (6) , 631-41
Defining the human targets of phorbol ester and diacylglycerol.
Phorbol esters (PEs) and their derivatives are potent tumor-promoting agents. The best known receptors for these substances are the novel and classical isotypes of protein kinase C (PKC), which bind PE and the physiological second messenger diacylglycerol (DAG) by cysteine-rich domains, the C1 domains. However, PKC is not the sole receptor of PE, a concept that has been largely ignored in the past. PE (in addition to DAG) also targets C1-containing receptors unrelated to PKC. In order to get a better insight into DAG/PE-mediated signaling and the pathways involved, it is necessary to first determine all ligand-interacting proteins. Employing various sources of data, 66 different C1-containing human proteins are presented and predictions of their DAG/PE-binding potential are attempted. Defining the entire set of key mediators for the physiological DAG responses and for PE-induced tumorigenesis may aid our understanding of signal integration and can also help to design new strategies for therapeutic cancer intervention.